MD4502C1 - Лекарственное средство в виде геля для лечения заболеваний пародонта (варианты) - Google Patents
Лекарственное средство в виде геля для лечения заболеваний пародонта (варианты) Download PDFInfo
- Publication number
- MD4502C1 MD4502C1 MDA20160139A MD20160139A MD4502C1 MD 4502 C1 MD4502 C1 MD 4502C1 MD A20160139 A MDA20160139 A MD A20160139A MD 20160139 A MD20160139 A MD 20160139A MD 4502 C1 MD4502 C1 MD 4502C1
- Authority
- MD
- Moldova
- Prior art keywords
- extract
- calculated
- dry substance
- gel
- treatment
- Prior art date
Links
- 208000028169 periodontal disease Diseases 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 title abstract description 7
- 229940079593 drug Drugs 0.000 title abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 71
- 239000000126 substance Substances 0.000 claims abstract description 51
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 102000008186 Collagen Human genes 0.000 claims abstract description 28
- 108010035532 Collagen Proteins 0.000 claims abstract description 28
- 229920001436 collagen Polymers 0.000 claims abstract description 28
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 26
- 240000007049 Juglans regia Species 0.000 claims abstract description 23
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000005708 Sodium hypochlorite Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002028 Biomass Substances 0.000 claims abstract description 19
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 18
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 18
- 241001464430 Cyanobacterium Species 0.000 claims abstract description 18
- 239000004014 plasticizer Substances 0.000 claims abstract description 15
- 240000003291 Armoracia rusticana Species 0.000 claims abstract description 14
- 235000011330 Armoracia rusticana Nutrition 0.000 claims abstract description 14
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 12
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 12
- 239000000499 gel Substances 0.000 claims description 27
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 229920002674 hyaluronan Polymers 0.000 claims description 21
- 229960003160 hyaluronic acid Drugs 0.000 claims description 21
- 159000000000 sodium salts Chemical class 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 235000020234 walnut Nutrition 0.000 claims description 13
- 235000011187 glycerol Nutrition 0.000 claims description 11
- 108010010803 Gelatin Proteins 0.000 claims description 10
- 230000009471 action Effects 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- 230000002035 prolonged effect Effects 0.000 claims description 8
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 3
- 241000206672 Gelidium Species 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 235000010419 agar Nutrition 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 229940049638 carbomer homopolymer type c Drugs 0.000 claims description 3
- 229940082484 carbomer-934 Drugs 0.000 claims description 3
- 229940043234 carbomer-940 Drugs 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 229960003943 hypromellose Drugs 0.000 claims description 3
- 241000758789 Juglans Species 0.000 claims 6
- KIUKXJAPPMFGSW-YXBJCWEESA-N (2s,4s,5r,6s)-6-[(2s,3r,5s,6r)-3-acetamido-2-[(3s,4r,5r,6r)-6-[(3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@@H]3[C@@H]([C@@H](O)C(O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)C(C(O)=O)O1 KIUKXJAPPMFGSW-YXBJCWEESA-N 0.000 abstract description 2
- 239000003349 gelling agent Substances 0.000 abstract description 2
- 230000002459 sustained effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 description 15
- 230000003239 periodontal effect Effects 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 230000035876 healing Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 description 8
- 230000002421 anti-septic effect Effects 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 201000001245 periodontitis Diseases 0.000 description 8
- 229940010747 sodium hyaluronate Drugs 0.000 description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000014571 nuts Nutrition 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000000843 anti-fungal effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- -1 chlorbenzyl alcohol Chemical compound 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 3
- 208000003433 Gingival Pocket Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000027866 inflammatory disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 239000008164 mustard oil Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 208000005888 Periodontal Pocket Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000001250 calendula officinalis l. absolute Substances 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 201000005562 gingival recession Diseases 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 210000004261 periodontium Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 244000180419 Brassica nigra Species 0.000 description 1
- 235000011291 Brassica nigra Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000008887 Dental Deposits Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010072574 Periodontal inflammation Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003501 anti-edematous effect Effects 0.000 description 1
- 230000000141 anti-hypoxic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000001277 chronic periodontitis Diseases 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004090 etiopathogenesis Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000000399 hydroalcoholic extract Substances 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000403 immunocorrecting effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002351 pectolytic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000035409 positive regulation of cell proliferation Effects 0.000 description 1
- 230000015323 positive regulation of phagocytosis Effects 0.000 description 1
- QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Изобретение относится к области медицины, а именно к лекарственному средству пролонгированного действия, которое может быть использовано для лечения заболеваний пародонта.Лекарственное средство пролонгированного действия в виде геля для лечения заболеваний пародонта включает гелеобразующий агент 5,0…10,0 г, пластификатор 0,5…2,0 г, гипохлорит натрия 0,5…1,0 г, коллаген 5,0…10,0 г, натриевую соль гиалуроновой кислоты 0,5…2,0 г, диметилсульфоксид 1,0…3,0 г, экстракт из скорлупы спелых орехов (Juglans regia L.) из расчета на сухое вещество 0,5…1,0 г, экстракт из биомассы штамма цианобактерии Spirulina platensis из расчета на сухое вещество 0,5…2,5 г и воду 100 мл; также может содержать экстракт цветков Calendula officinalis L. из расчета на сухое вещество 3,5…5,0 г и экстракт корней Armoracia rusticana Lam. из расчета на сухое вещество 0,5…1,0 г или их комбинации.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20160139A MD4502C1 (ru) | 2016-12-15 | 2016-12-15 | Лекарственное средство в виде геля для лечения заболеваний пародонта (варианты) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20160139A MD4502C1 (ru) | 2016-12-15 | 2016-12-15 | Лекарственное средство в виде геля для лечения заболеваний пародонта (варианты) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4502B1 MD4502B1 (ru) | 2017-08-31 |
| MD4502C1 true MD4502C1 (ru) | 2018-03-31 |
Family
ID=59759575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20160139A MD4502C1 (ru) | 2016-12-15 | 2016-12-15 | Лекарственное средство в виде геля для лечения заболеваний пародонта (варианты) |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4502C1 (ru) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996026707A1 (en) * | 1995-02-28 | 1996-09-06 | U.S. Meds - Bulgaria Ltd. | Composition for hygiene, prophylaxis and treatment of the oral cavity |
| RU2158125C1 (ru) * | 1999-11-17 | 2000-10-27 | Санкт-Петербургская медицинская академия последипломного образования | Состав для профилактики и лечения заболеваний пародонта и слизистой оболочки полости рта |
| RU2188627C1 (ru) * | 2001-04-26 | 2002-09-10 | ООО НПО "Фитофарм" | Состав для профилактики заболеваний полости рта |
| RU2286764C1 (ru) * | 2005-06-16 | 2006-11-10 | Георгий Георгиевич Ростиашвили | Средство "гиалудент" пролонгированного действия для лечения воспалительных заболеваний полости рта |
| JP2007037635A (ja) * | 2005-08-01 | 2007-02-15 | Hitachi Medical Corp | 歯周組織再生用ゲル化組成物 |
| MD3905F1 (en) * | 2008-05-07 | 2009-05-31 | Valeriu Fala | Remedy of durable action in the form of gel for treatment of parodentium affections (variants) |
| UA91666U (ru) * | 2014-02-24 | 2014-07-10 | Роман Михайлович Федін | Фитосредство в форме геля для профилактики и лечения заболеваний пародонта |
-
2016
- 2016-12-15 MD MDA20160139A patent/MD4502C1/ru not_active IP Right Cessation
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996026707A1 (en) * | 1995-02-28 | 1996-09-06 | U.S. Meds - Bulgaria Ltd. | Composition for hygiene, prophylaxis and treatment of the oral cavity |
| RU2158125C1 (ru) * | 1999-11-17 | 2000-10-27 | Санкт-Петербургская медицинская академия последипломного образования | Состав для профилактики и лечения заболеваний пародонта и слизистой оболочки полости рта |
| RU2188627C1 (ru) * | 2001-04-26 | 2002-09-10 | ООО НПО "Фитофарм" | Состав для профилактики заболеваний полости рта |
| RU2286764C1 (ru) * | 2005-06-16 | 2006-11-10 | Георгий Георгиевич Ростиашвили | Средство "гиалудент" пролонгированного действия для лечения воспалительных заболеваний полости рта |
| JP2007037635A (ja) * | 2005-08-01 | 2007-02-15 | Hitachi Medical Corp | 歯周組織再生用ゲル化組成物 |
| MD3905F1 (en) * | 2008-05-07 | 2009-05-31 | Valeriu Fala | Remedy of durable action in the form of gel for treatment of parodentium affections (variants) |
| UA91666U (ru) * | 2014-02-24 | 2014-07-10 | Роман Михайлович Федін | Фитосредство в форме геля для профилактики и лечения заболеваний пародонта |
Also Published As
| Publication number | Publication date |
|---|---|
| MD4502B1 (ru) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8383100B2 (en) | Method to treat and prevent skin diseases with Porifera-based therapeutic compositions treating and preventing skin diseases | |
| CN105213298A (zh) | 一种口腔护理凝胶及其制备方法 | |
| CN110772475A (zh) | 一种益生菌牙膏 | |
| CN109481527B (zh) | 一种制备预防或治疗口腔疾病的中药组合物及其应用 | |
| CN102961744A (zh) | 一种用于保湿的组合物 | |
| CN105963237B (zh) | 一种新型漱口液及其制备方法和用途 | |
| RU2286764C1 (ru) | Средство "гиалудент" пролонгированного действия для лечения воспалительных заболеваний полости рта | |
| CN108542805A (zh) | 祛痘复方精油制剂及其制备方法和应用 | |
| RU2505283C1 (ru) | Композиция зубной пасты | |
| CN107242983B (zh) | 一种含艾叶黄酮的漱口水及其制备方法 | |
| RU2356551C1 (ru) | Способ лечения плоского лишая слизистой оболочки полости рта | |
| MD4502C1 (ru) | Лекарственное средство в виде геля для лечения заболеваний пародонта (варианты) | |
| Isadkar et al. | Aloe vera as denture cleanser | |
| RU2548505C1 (ru) | Способ лечения хронических апикальных периодонтитов | |
| Farman et al. | Aloe Vera in Dentistry: A Review | |
| CN108030729A (zh) | 一种抑菌牙膏 | |
| RU2400174C1 (ru) | Способ местного лечения воспалительных заболеваний пародонта | |
| CN107456567A (zh) | 一种防裂消肿修复滋润的足跟膏及其制备方法 | |
| RU2095077C1 (ru) | Противовоспалительная общеукрепляющая лекарственная смесь из натуральных и растительных продуктов | |
| KR101910716B1 (ko) | 녹차 함유 구강세척제 | |
| MD4503C1 (ru) | Композиция для лекарственной пленки для лечения болезней пародонта и поражений слизистой оболочки полости рта (варианты) | |
| RU2345782C2 (ru) | Терапевтические композиции на основе porifera для лечения и предотвращения кожных заболеваний | |
| CN107982145A (zh) | 一种含黄芩提取物的抗菌牙膏 | |
| ES2463425T3 (es) | Composiciones terapéuticas basadas en Spongilla para tratar y prevenir el acné | |
| CN106580770A (zh) | 一种美齿防护牙膏 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |